2019 UEM Edgenta Annual Report

132 133 UEM EDGENTA AT A GLANCE MESSAGE FROM OUR LEADERSHIP STRATEGIC FOCUS OPERATIONAL REVIEW SUSTAINABILITY EFFORTS CORPORATE GOVERNANCE INTRODUCTION FINANCIAL REVIEW ADDITIONAL INFORMATION UEM Edgenta Berhad Annual Report 2019 Directors’ Report DIRECTORS The names of the directors of the Company in office since the beginning of the financial year to the date of this report are: Tan Sri Dr. Azmil Khalili bin Dato’ Khalid (Appointed on 24 May 2019) Dato’ Azmir Merican bin Azmi Merican* Dato’ Mohd Izani bin Ghani (Appointed on 22 October 2019) Dato’ Noorazman bin Abd Aziz Tan Bun Poo Elakumari a/p Kantilal Juniwati Rahmat Hussin Dato’ George Stewart LaBrooy Emily Kok Rowina Ghazali Seth Dr. Saman @ Saimy bin Ismail (Demised on 29 April 2019) Amir Hamzah bin Azizan (Retired on 15 May 2019) Mohd Shahazwan bin Mohd Harris (Alternate to Dato’ Noorazman bin Abd Aziz) (Resigned on 28 February 2019) * These directors are also directors of certain subsidiaries of the Company. The names of the directors of the subsidiaries of the Company since the beginning of the financial year to the date of this report (not including those directors listed above) are: Chan Cheow Hong Chen Yen-Yu Dr. Chan Tuck Leong Fardan bin Abdul Majeed Graeme Walwyn Huang Wan Hung Jesudason Selvaraj John Bong Kim Fook Lim Wah Seng Low Chee Yen Mazli bin Mohamed Ayob Mohamad Zamani bin Razali Mohd Razif bin Mohd Yusoff Muhammad Noor bin Abd Aziz @ Hashim Nurolamin bin Abas Philippa Smith Lambert Ramlan bin Khamis Roli Shukla Saeed Abdulla Omar Saeed Al Amoudi Sharon Ruba a/p Krishnamurthy Sitthambaranatha Gandhi a/l Suppiah Sivaramakrishnan Narayanan Ayakkad Suriana binti Abdul Hamid Tan Cheh Tian Tan Sri Dato’ Chen Kooi Chiew @ Cheng Ngi Chong Tan Sri Datuk Chen Lok Loi Tan Wan San (Alternate to Tan Sri Dato’ Chen Kooi Chiew @ Cheng Ngi Chong) Shariman Yusuf bin Mohamed Zain (Appointed on 28 February 2020) Paul Sandanasamy Richard (Appointed on 15 January 2019) Dr. Nik Fawaz bin Nik Abdul Aziz (Appointed on 1 January 2020) Leong Kar Yung (Appointed on 13 January 2020) Razman Ismail (Appointed on 13 January 2020) Rakesh Devasish Jena (Alternate to Dr. Chan Tuck Leong) (Appointed on 29 August 2019) Lim Wei Hsien Kenny (Appointed on 20 June 2019) DIRECTORS (CONT’D.) The names of the directors of the subsidiaries of the Company since the beginning of the financial year to the date of this report (not including those directors listed above) are: (cont’d.) Mohd Khalil bin Dan (Appointed on 10 June 2019 and resigned on 28 February 2020) Ahmad Zamri bin Said (Resigned on 28 February 2020) Alastair Douglas McCracken (Resigned on 21 June 2019) Azmy bin Mahbot (Resigned on 22 January 2020) Chin Chi Haw (Resigned on 19 July 2019) Dr. Tee Kim Siong (Resigned on 26 November 2019) Primoehadi Notowidigdo (Resigned on 28 February 2020) Mohamed bin Rastam Shahrom (Resigned on 15 January 2019) Mohd Azlan bin Abas (Resigned on 30 November 2019) Paul Sandanasamy Richard (Alternate to Azmy bin Mahbot) (Resigned on 15 January 2019) Rakesh Devasish Jena (Alternate to Chin Chi Haw) (Resigned on 19 July 2019) Sofia binti Zakaria (Resigned on 14 January 2020) Tay Tuan Leng (Resigned on 21 August 2019) Director of a subsidiary that has been disposed during the financial year: Haji Zohari bin Mahur (Disposed on 27 September 2019) DIRECTORS’ BENEFITS Neither at the end of the financial year, nor at any time during that year, did there subsist any arrangement to which the Company was a party, whereby the directors might acquire benefits by means of the acquisition of shares in or debentures of the Company or any other body corporate. Since the end of the previous financial year, no director has received or become entitled to receive a benefit (other than benefits included in the aggregate amount of emoluments received or due and receivable by the directors or the fixed salary of a full time employee of the Company as shown below) by reason of a contract made by the Company or a related corporation with any director or with a firm of which the director is a member, or with a company in which the director has a substantial financial interest. The directors’ benefits are as follows: Group RM’000 Company RM’000 Executive: Salaries and other emoluments 996 996 Bonus 471 471 Contributions to defined contribution plans 219 219 Allowances 140 140 Benefits-in-kind 39 39 1,865 1,865 Non-Executive: Fees 1,287 1,243 Benefits-in-kind 40 40 1,327 1,283 Total 3,192 3,148 Directors’ Report